Shun Yamamoto
9PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 17, 2026
Clinical role of anti-PD-1 immunotherapies in esophageal cancer.Momoko Sano, Hiroshi Imazeki, Shun Yamamoto
|Mar 05, 2026
ISDE guidelines on the management of cT2N0 esophageal cancer.Geoffrey P Kohn, Virginia Litle, Yousif Eliya
|Apr 21, 2025
Tislelizumab for the treatment of advanced esophageal squamous cell carcinoma.Kazuhiro Shiraishi, Shun Yamamoto, Ken Kato
|Mar 29, 2025
Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma.Zachary A Cooper, Ying Wang, Philip L Martin
|Sep 27, 2024
Factors influencing decision-making between surgery and chemoradiotherapy for esophageal carcinoma from the JCOG0502.Shun Yamamoto, Ken Kato, Hiroyuki Daiko
|Dec 21, 2023
Nivolumab in unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma.Go Ikeda, Jun Miyakoshi, Shun Yamamoto
Pageof 2
Frequent Collaborators
5 joint publications
Ken Kato
1 joint publications
Kengo Nagashima
1 joint publications
Go Ikeda
1 joint publications
Zachary A Cooper
1 joint publications
Ying Wang
1 joint publications
Philip L Martin
1 joint publications
Kosho Murayama
1 joint publications
Rakesh Kumar
1 joint publications
Ken Kato
1 joint publications
Shigeki Sekine
